TAYLOR FITZPATRICK: Open Payments
NPI 1376263186 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 37 payments from 13 companies in 2025. Trend: 2023 $492 · 2024 $526 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $182 |
| Exact Sciences Corporation | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Lilly USA, LLC | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Globus Medical, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: VRAYLAR, UBRELVY, Cologuard Collection Kit, MOUNJARO, NEXLETOL, Wegovy, SHINGRIX, Senza.
Industry payments across OK — which companies pay providers there.
